Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$7.20
+1.7%
$9.31
$2.09
$14.84
$501.94M0.053.22 million shs2.31 million shs
American Tower Co. stock logo
AMT
American Tower
$172.96
-0.2%
$190.60
$154.58
$219.10
$80.84B0.672.61 million shs1.86 million shs
QCC
Quadron Cannatech
$0.27
$0.16
$0.77
N/AN/A32,330 shsN/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
+1.69%+4.50%-16.76%-22.83%+37.93%
American Tower Co. stock logo
AMT
American Tower
-0.22%+1.15%-10.89%-12.33%-13.67%
QCC
Quadron Cannatech
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
1.3769 of 5 stars
3.31.00.00.03.21.70.0
American Tower Co. stock logo
AMT
American Tower
4.9831 of 5 stars
4.45.02.53.12.82.51.9
QCC
Quadron Cannatech
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
2.67
Moderate Buy$15.00108.33% Upside
American Tower Co. stock logo
AMT
American Tower
2.82
Moderate Buy$217.3625.67% Upside
QCC
Quadron Cannatech
N/AN/AN/AN/A

Current Analyst Ratings

Latest QCC, ADR, AMT, and ALT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
American Tower Co. stock logo
AMT
American Tower
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$183.00 ➝ $196.00
4/8/2024
American Tower Co. stock logo
AMT
American Tower
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$205.00
4/1/2024
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
3/28/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
3/5/2024
American Tower Co. stock logo
AMT
American Tower
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$224.00 ➝ $234.00
2/28/2024
American Tower Co. stock logo
AMT
American Tower
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$235.00 ➝ $228.00
2/28/2024
American Tower Co. stock logo
AMT
American Tower
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$236.00 ➝ $230.00
2/13/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$430K1,187.00N/AN/A$2.75 per share2.62
American Tower Co. stock logo
AMT
American Tower
$11.14B7.24$9.88 per share17.50$23.30 per share7.42
QCC
Quadron Cannatech
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$88.45M-$1.65N/AN/AN/A-20,780.75%-44.77%-40.72%5/9/2024 (Estimated)
American Tower Co. stock logo
AMT
American Tower
$1.48B$3.1854.3916.761.3713.31%12.80%2.24%4/30/2024 (Confirmed)
QCC
Quadron Cannatech
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest QCC, ADR, AMT, and ALT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
American Tower Co. stock logo
AMT
American Tower
$2.45N/A-$2.45N/AN/AN/A  
3/27/2024Q4 2023
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.35-$0.33+$0.02-$0.12N/A$0.04 million
2/27/202412/31/2023
American Tower Co. stock logo
AMT
American Tower
$2.10$0.94-$1.16$0.18$2.74 billion$2.79 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
American Tower Co. stock logo
AMT
American Tower
$6.483.75%+12.50%203.77%N/A
QCC
Quadron Cannatech
N/AN/AN/AN/AN/A

Latest QCC, ADR, AMT, and ALT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/14/2024
American Tower Co. stock logo
AMT
American Tower
quarterly$1.623.3%4/11/20244/12/20244/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
17.26
17.26
American Tower Co. stock logo
AMT
American Tower
3.29
0.69
0.69
QCC
Quadron Cannatech
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
78.05%
American Tower Co. stock logo
AMT
American Tower
92.69%
QCC
Quadron Cannatech
N/A

Insider Ownership

CompanyInsider Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
4.10%
American Tower Co. stock logo
AMT
American Tower
0.24%
QCC
Quadron Cannatech
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5970.89 million67.99 millionOptionable
American Tower Co. stock logo
AMT
American Tower
5,643466.35 million465.23 millionOptionable
QCC
Quadron Cannatech
N/AN/AN/ANot Optionable

QCC, ADR, AMT, and ALT Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Altimmune logo

Altimmune

NASDAQ:ALT
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
American Tower logo

American Tower

NYSE:AMT
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.

Quadron Cannatech

CNSX:QCC
Quadron Cannatech Corporation, an automated extraction and processing solutions company, provides ancillary equipment, products, and services for authorized cannabis industry participants in Canada. The company offers design and manufacturing extraction, processing, and production equipment for lease/sale; and packages and sells consumption and dispensing hardware and supplies. It also involved in the laboratory analytics, organic compound extraction, distillation, purification, and formulation development activities; and research and development activities in the areas of engineering, process automation, manufacturing, development of standards and IP related to extraction, processing and refinement, advanced cannabis chemistry, product development, analytical testing, best practices, and others. In addition, the company offers extract and product development consultation services, custom ancillary solutions, branded consumption devices, and packaging services, as well as vapor pens for medical and recreational consumers. Further, it provides process technical services; automation systems; standard and custom machines; VFD/drive and robotic-XY systems; and turnkey solutions, including shop and field machine based services, custom machining, and field repairs. Additionally, the company designs and supplies heat transfer systems, such as cooling systems, chillers, resin systems, melters, process heat systems, reverse osmosis systems, and cooling towers; designs and repairs custom electronics and communications interfaces; and supplies control packages. The company was formerly known as Quadron Capital Corporation and changed its name to Quadron Cannatech Corporation in May 2017. Quadron Cannatech Corporation was incorporated in 2011 and is headquartered in Vancouver, Canada.